Related references
Note: Only part of the references are listed.Cognitive Factors Associated with Adherence to Oral Antiestrogen Therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study
Heidi D. Klepin et al.
CANCER PREVENTION RESEARCH (2014)
Effect of Endocrine Therapy on Quality of Life and Cognitive Functions in Patients with Breast Cancer
Saadettin Kilickap et al.
BREAST CARE (2013)
Positive and negative affect, depression, and cognitive processes in the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Trial
Suzanne C. Danhauer et al.
AGING NEUROPSYCHOLOGY AND COGNITION (2013)
Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors
Lynn M. Breckenridge et al.
PSYCHO-ONCOLOGY (2012)
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study
C. M. T. Schilder et al.
PSYCHO-ONCOLOGY (2012)
Stress, Coping and Cognitive Deficits in Women After Surgery for Breast Cancer
Stephanie A. Reid-Arndt et al.
JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS (2012)
Aromatase expression in the normal and epileptic human hippocampus
Josue G. Yague et al.
BRAIN RESEARCH (2010)
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial
Kelly-Anne Phillips et al.
BREAST (2010)
Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer
Lisa Lejbak et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2010)
Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial
Christina M. Schilder et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cognitive changes associated with endocrine therapy for breast cancer
Kunal Agrawal et al.
MATURITAS (2010)
Cognitive limitations in occupationally active malignant brain tumour survivors
Lisseth Calvio et al.
OCCUPATIONAL MEDICINE-OXFORD (2009)
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study
Barbara Collins et al.
PSYCHO-ONCOLOGY (2009)
Anastrozole: brain draining or sparing?
Sarah L. Berga
LANCET ONCOLOGY (2008)
Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II)
Valerie A. Jenkins et al.
LANCET ONCOLOGY (2008)
Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls
Jaime L. Palmer et al.
Journal of Cancer Survivorship (2008)
Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer
Catherine M. Bender et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2007)
Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen
Eric A. Ariazi et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition?
Valerie Jenkins et al.
EUROPEAN JOURNAL OF CANCER (2007)
Cognitive function during neoadjuvant chemotherapy for breast cancer -: Results of a prospective, multicenter, longitudinal study
Kerstin Hermelink et al.
CANCER (2007)
A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer
V Jenkins et al.
BRITISH JOURNAL OF CANCER (2006)
The (mis)classification of chemo-fog - methodological inconsistencies in the investigation of cognitive impairment after chemotherapy
V Shilling et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Aromatase inhibitors in the treatment of breast cancer
RW Brueggemeier et al.
ENDOCRINE REVIEWS (2005)
Evidence that androgenic and estrogenic metabolites contribute to the effects of dehydroepiandrosterone on cognition in postmenopausal women
E Hirshman et al.
HORMONES AND BEHAVIOR (2004)
Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen
SA Castellon et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2004)
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study
V Jenkins et al.
PSYCHO-ONCOLOGY (2004)
The effects of hormone therapy on cognition in breast cancer
V Shilling et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Appraisal and psychological distress six months after diagnosis of breast cancer
J Gallagher et al.
BRITISH JOURNAL OF HEALTH PSYCHOLOGY (2002)
Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma
TA Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women:: a sub-protocol of the 'Arimidex™ and Tamoxifen Alone or in Combination' (ATAC) trial
M Baum et al.
BRITISH JOURNAL OF CANCER (2001)
Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen
A Paganini-Hill et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Share Paper
